There are lots of ways you can increase weight in the gym. But we’ll focus on two good ones. If you are a beginner, using the ...

Investigators assessed markers of chronic kidney disease (CKD) with cancer risks using data from more than one million patients.

KDIGO's new IgA nephropathy guideline shifts the treatment paradigm from supportive care alone to targeting the disease's immunologic nature.

GFR is key marker of kidney function; IgAN is progressive autoimmune kidney disease that leads to kidney failure in many patients 1-3 Fabhalta is first and only approved complement inhibitor for ...

A new study published in the journal of Pediatric Nephrology revealed an U-shaped relationship between serum uric acid levels and cardiovascular risk in children with chronic kidney disease ...

Patients with lupus nephritis who received hydroxychloroquine demonstrated a significantly lower risk for glomerular ...

CKD is a widespread condition that not only increases the risk of kidney failure but also significantly raises the risk of developing various forms of cardiovascular disease. A re ...

The approval was based on the SOUL trial, which evaluated oral semaglutide in adults 50 years and older with T2DM and established CV disease and/or chronic kidney disease.

In short, managing kidney disease without dialysis means eating the right foods, exercising, keeping blood pressure and blood ...

The Food and Drug Administration (FDA) has approved Gazyva ® (obinutuzumab) for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.

Final results were announced from the phase 3 APPLAUSE-IgAN trial evaluating iptacopan in patients with IgA nephropathy.